Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system

Research output: Contribution to journalReviewResearchpeer-review

Apolipoprotein M (apoM) is a member of the lipocalin superfamily and is predominantly associated with high-density lipoprotein (HDL). It was found that apoM is the chaperon to the bioactive sphingolipid, sphingosine-1-phosphate (S1P). Several studies have since contributed to expand the knowledge on apoM, S1P, and the apoM/S1P-complex in cardiovascular diseases. For instance, the HDL-bound apoM/S1P complex serves as a bridge between HDL and endothelial cells, maintaining a healthy endothelial barrier. Evidence indicates, however, that the apoM/S1P complex may has both protective and harmful effects on the cardiovascular system, which suggests the need for more research to understand the interplay between these molecules. This review aims to shed light on the most recent findings on apoM/S1P-signaling and its impact on endothelial dysfunction, inflammation, and cardiovascular diseases. Finally, it will be discussed whether drugs that target apoM and/or S1P-signaling may be beneficial to patients with cardiovascular and inflammatory diseases.

Original languageEnglish
Pages (from-to)76-84
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors

    Research areas

  • Apolipoprotein M, Cardiovascular disease, Endothelial dysfunction, Inflammation, Lipid metabolism, Sphingosine-1-phosphate

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 281604012